Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization

Howard M. Ross, Lawrence W. Weber, Siqun Wang, Gregory Piskun, Ruben Dyall, Ping Song, Yoshizumi Takechi, Janko Nikolić-Zugić, Alan N. Houghton, Jonathan J. Lewis

Research output: Contribution to journalArticlepeer-review

42 Scopus citations


DNA immunization has been shown to elicit both antibody and CTL responses against antigens expressed by infections organisms. Because CTL responses have been implicated in rejection of cancer, we investigated whether DNA immunization by particle bombardment using a gene gun could induce CTL responses that were capable of rejecting tumors in mice. DNA immunization by particle bombardment using genes encoding β-galactosidase and ovalbumin primed mice to generate CTLs in two genetic backgrounds (DBA/2 and C57BL/6 strains, respectively). DNA immunization was more potent in inducing CTLs than immunization with an optimized regimen of ovalbumin peptide plus immune adjuvant. Immunity induced by DNA immunization protected mice against s.c. challenge with tumors expressing the β-galactosidase antigen. Tumors were rejected even when DNA immunization was started 3 or 7 days after tumor challenge as tumors were becoming established. Tumor rejection required CD8+ T cells, confirming a role for CTLs in vivo. These studies show that DNA immunization by particle bombardment can efficiently induce CTL responses that are capable of rejecting even established tumors.

Original languageEnglish (US)
Pages (from-to)2191-2196
Number of pages6
JournalClinical Cancer Research
Issue number12 I
StatePublished - Dec 1997

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization'. Together they form a unique fingerprint.

Cite this